Global registry tracks Real-World safety of gut drug
NCT ID NCT01990040
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study is a global registry that follows people with short bowel syndrome (SBS) over time to see how safe and effective the drug teduglutide is in everyday medical practice. About 1,800 participants, both those taking teduglutide and those not, will be observed. The main goal is to track any cases of colorectal cancer and other health issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shire
Lexington, Massachusetts, 02421, United States
Conditions
Explore the condition pages connected to this study.